GlassScriptPhysician profile
Joel J Johnson
NPI 1528138542
$5,246.46
in general payments reported to CMS, 2019-2025
42 companies · $780 in 2025
The $780 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $435 · 2021: $926 · 2022: $701 · 2023: $861 · 2024: $913 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,460 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,460.15 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,461.15 | 2019-2025 | Evenity, Prolia, Otezla |
| Merck Sharp & Dohme LLC | $483.37 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Astellas Pharma US INC | $439.70 | 2019-2025 | Veozah |
| Pfizer INC. | $393.62 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $306.42 | 2019-2022 | |
| Lilly USA, LLC | $216.64 | 2019-2025 | Taltz, Mounjaro, Zepbound |
| Novo Nordisk INC | $171.85 | 2023-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $160.06 | 2019-2024 | |
| Phathom Pharmaceuticals, INC. | $146.73 | 2024-2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $138.75 | 2023-2025 | Dupixent |
| Abbvie INC. | $133.10 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $125.49 | 2019-2024 | Eliquis |
| Smith+Nephew, INC. | $108.41 | 2019-2023 | Grafix Pl |
| Eisai INC. | $69.58 | 2021 | |
| Kyowa Kirin, INC. | $64.62 | 2023-2025 | Crysvita |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.